Gary B Ruvkun

Graduated from:

University of California, Berkeley (USA)
Harvard University (USA)

USPTO Granted Patents = 14 (Patent Applications = 2)

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 3.1

ph-index = 2

Forward Citations = 14(Granted Patents)

Location History:

Cambridge, MA (US) (2002)
Newton, MA (US) (2001 - 2024)

Company Filing History:

14 out of 2,890

The General Hospital Corporation

patents

1 out of 8

The Netherlands Cancer Institute

patents

where one patent can have more than one assignee

Years Active: 2001-2024

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12065648 - Methods and compositions for inhibiting detoxification response (2024-08-20),

2. 11738056 - Compositions and methods for improving mitochondrial function (2023-08-29),

3. 11001870 - Carotenoids for treating or preventing nausea (2021-05-11),

4. 10988765 - Methods and compositions for inhibiting detoxification response (2021-04-27),

5. 10973860 - Compositions and methods for improving mitochondrial function (2021-04-13),

6. 7414169 - Therapeutic and diagnostic tools for impaired glucose tolerance conditions (2008-08-19),

7. 7175999 - Polynucleotide and polypeptide fat metabolism regulators and uses thereof (2007-02-13),

8. 7166270 - Methods of screening compounds useful for prevention of infection or pathogenicity (2007-01-23),

9. 7094889 - AGE-1 polypeptides and related molecules and methods (2006-08-22),

10. 7041437 - Therapeutic and diagnostic tools for impaired glucose tolerance conditions (2006-05-09),

11. 6905670 - Methods of screening compounds useful for prevention of infection or pathogenicity (2005-06-14),

12. 6861256 - Therapeutic and diagnostic tools for impaired glucose tolerance conditions (2005-03-01),

13. 6461854 - Methods of screening compounds useful for prevention of infection or pathogenicity (2002-10-08),

14. 6225120 - Therapeutic and diagnostic tools for impaired glucose tolerance conditions (2001-05-01),

Gary Ruvkun, a 2024 Nobel Prize laureate in Physiology or Medicine, has profoundly shaped our understanding of genetic regulation and aging. As a molecular biologist and professor at Harvard Medical School, Ruvkun’s groundbreaking research on microRNAs, tiny RNA molecules that regulate gene expression, has unveiled a new dimension of biological control mechanisms. His pioneering work with the nematode C. elegans revealed how these small RNAs influence the development and longevity of organisms. This discovery has broad implications for aging, disease, and biotechnology. Alongside his research partner, Victor Ambros, Ruvkun’s contributions have expanded the frontier of molecular biology, revealing insights into RNA interference and its therapeutic potential. His intellectual rigor and relentless curiosity have earned him a place among the most esteemed scientists of our time.